Autor/in Möbus, V Harbeck, N 2 Huober, J 2 Jackisch, C 2 Schneeweiss, A 2 von Minckwitz, G 2 Berdel, W E 1 Conrad, B 1 Elling, D 1 Fehm, T 1 Frickhofen, N 1 Koenigsmann, M 1 Kröger, Nicolaus 1 Krüger, W 1 Kuhn, W 1 Lück, H J 1 Lück, H-J 1 Metzner, B 1 Nitz, U 1 Schmoor, C 1 Tesch, H 1 Thiel, E 1 Thomssen, C 1 Wandt, H 1 Zander, Axel R. 1 du Bois, A 1 alle zeigenListe einklappen
Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial Möbus, V Jackisch, C Lück, H J du Bois, A Thomssen, C Kuhn, W Nitz, U 2018 - Forschungsinformationssystem des UKE
German Adjuvant Intergroup Node-positive Study (GAIN):a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients Möbus, V von Minckwitz, G Jackisch, C Lück, H-J Schneeweiss, A Tesch, H Elling, D 2017 - Forschungsinformationssystem des UKE
Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-up. Zander, Axel R. Schmoor, C Kröger, Nicolaus Krüger, W Möbus, V Frickhofen, N Metzner, B 2008 - Forschungsinformationssystem des UKE
